Latest Fund Strategy News

Minbos Resources Limited reported a challenging quarter with significant cash outflows but plans a $1 million share purchase plan to bolster its funding position.

Cadoux Limited has made significant progress in its High Purity Alumina (HPA) project and its 50% owned Minhub rare earths processing initiative, advancing engineering design and market engagement amid growing global demand for critical minerals.

Seafarms Group has completed the acquisition of Project Sea Dragon's assets, clearing legal hurdles and advancing its prawn farming operations while actively pursuing new funding to support growth.

Alterity Therapeutics has bolstered its Phase 2 data for ATH434 in Multiple System Atrophy and is advancing regulatory plans for a pivotal Phase 3 trial, supported by a robust cash position of A$49.2 million.

Infinity Metals Limited reported a steady cash position of A$2.25 million at the end of December 2025, with operational spending continuing but no new financing activities. The company estimates funding for over five quarters based on current expenditure.

Beetaloo Energy Australia Limited reported a solid cash position of $17.96 million at the end of December 2025, supported by $6.8 million in unused financing facilities. The company’s liquidity covers approximately 2.6 quarters of current cash outflows, positioning it well as it awaits the activation of a new $30 million infrastructure facility.

88 Energy Limited has significantly expanded its Alaskan North Slope acreage and progressed its farm-out strategy despite regulatory delays, while maintaining a solid cash position to support ongoing exploration.

Dotz Nano has achieved a key production milestone for its proprietary CO2 sorbent materials and raised over AU$3 million to accelerate commercialization of its DotzEarth technology.

Zoono Group has landed its first commercial orders from three new packaging partners, marking a key milestone in its fresh food shelf-life extension strategy. The company reports NZ$551,000 cash on hand as it navigates growth and funding options.

Patagonia Lithium reported promising lithium assay results from ongoing drilling in Argentina and has secured a strategic funding partnership to support its next development phase.

Neurizon Therapeutics has locked in a $6 million cash rebate from the Australian Government’s R&D Tax Incentive, underpinning its upcoming HEALEY ALS Platform Trial with first patient dosing slated for early 2026.

NT Minerals Limited reported a mixed cash flow quarter ending December 2025, with ongoing operational losses offset by strong investing inflows and a solid funding buffer. The company signals confidence in continuing operations despite tight liquidity.